Micron, FedEx Set To Headline Earnings Next Week
Outlook Therapeutics Inc OTLK
$1.58
▼ -4.24%
($-0.07)
Open
$1.62
Prev Close
$1.65
Day Range
$1.40 – $1.66
52W Range
$0.16 – $3.39
Market Cap
$253.03M
Beta
0.76
EPS (TTM)
$-1.26
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-06-13 |
| Shares Out. | 160,150,000 |
| Website | outlooktherapeutics.com/ ↗ |
| Phone | 16096193990 |
Outlook Therapeutics Inc is a publicly traded company under the ticker symbol OTLK on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-06-01)
📰 Latest News for OTLK
Outlook Therapeutics Heads Into Another FDA PDUFA Decision For Lytenava
Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time
12 Health Care Stocks Moving In Tuesday's Intraday Session
Outlook Therapeutics Says FDA Accepts Resubmitted BLA For ONS-5010/LYTENAVA For Treatment Of Neovascular Age-Related Macular Degeneration; PDUFA Target Action Date July 29
12 Health Care Stocks Moving In Friday's Pre-Market Session
Traders are paying attention to the gapping stocks in Thursday's session.
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday